1.A Case Report of Lung Adenocarcinoma with EGFR G719A Mutation and LMNA-NTRK1 Fusion.
Shiqi SONG ; Yaxian YANG ; Weiquan LUO ; Yueya LIANG ; Qi LI ; Tongxu ZHUO ; Weibin XIONG ; Jian HUANG
Chinese Journal of Lung Cancer 2025;28(1):75-80
Fusion variations of neurotrophic receptor tyrosine kinase (NTRK) are oncogenic drivers in various solid tumors such as breast cancer, salivary gland carcinoma, infant fibrosarcoma, etc. Gene rearrangements involving NTRK1/2/3 lead to constitutive activation of the tropomyosin receptor kinase (TRK) domain, and the expressed fusion proteins drive tumor growth and survival. NTRK fusions are estimated to occur at a frequency of approximately 0.1% to 1% in non-small cell lung cancer (NSCLC). Epidermal growth factor receptor (EGFR) mutations are prevalent in NSCLC, but the frequency of EGFR G719A mutation is relatively low (about 2%), and EGFR mutations are typically mutually exclusive with NTRK fusion variants. The study presented the first documented case of lung adenocarcinoma harboring both EGFR G719A mutation and LMNA-NTRK1 fusion. A review of the literature was conducted to elucidate the role of NTRK fusion mutations in NSCLC and their relationship with EGFR mutations, aiming to enhance the understanding of NTRK fusion mutations in NSCLC.
.
Humans
;
Adenocarcinoma/genetics*
;
Adenocarcinoma of Lung
;
ErbB Receptors/genetics*
;
Lamin Type A/genetics*
;
Lung Neoplasms/genetics*
;
Mutation
;
Oncogene Proteins, Fusion/genetics*
;
Receptor, trkA/metabolism*
2.Progress of treatment-related hemophagocytic syndrome
Weibin ZHUO ; Chenghong WANG ; Zhiqiang SUN
Journal of Leukemia & Lymphoma 2021;30(11):695-697
Hemophagocytic syndrome (HPS) is a rare, life-threatening inflammatory response syndrome characterized by overactivation of the immune system, which leads to organ damage. Secondary HPS is usually triggered by infection, tumor and autoimmune disease. It has been clinically found that many HPS-like manifestations also occur during drug therapy. This article reviews the related progress of HPS induced by immune checkpoint inhibitors, ibrutinib and lamotrigine, in order to provide a guidance for clinical practice.
3.Detection of Human Papillomavirus Subtypes in Male Urethra in Xi'an Area
Wei HAN ; Wenkang LIU ; Weibin ZHAI ; Zhuo WU ; Enke ZHANG
Journal of Modern Laboratory Medicine 2017;32(3):52-55
Objective To investigate the infection of HPV subtypes in male urethra in Xi'an area.Methods The eighteen subtypes of HPV DNA were detected in 478 cases of male patients by PCR-reverse dot hybridization assay (RDB) including low risk subtypes (HPV6,11,43) and high risk subtypes (HPV16,18,31,33) during 2015~2016.Results The total infection rate of HPV subtypes in 478 subjects was 44.97% (215/478).The percents of subjects infected by one subtype,two ones,three ones,four ones and five ones were 32.85% (157/478),8.79% (42/478),2.09% (10/478),0.42% (2/478) and 0.84% (4/478),respectively.The detection rates of low risk subtypes and high risk ones were 40.17% and 22.38% in which the most common subtypes were HPV6 (24.69%),HPV11 (12.13%),HPV16 (5.65%),HPV43 (3.35%) and HPV52 (2.30%) and those of others were from 0% to 2.09%.The infection pattern of HPV subtypes gave priority to one subtype infection in all age groups.There was statistically different between H PVs (6,11,16,43,52,66) in twenty years or older subjects (x2 =12.879~109.7,P=0.000~0.025).Conclusion The majority of HPV subtypes detected in male urethra were HPV6,HPV11,HPV16,HPV43 and HPV52 in Xi'an area which provided epidemiological data for HPV infection in males.

Result Analysis
Print
Save
E-mail